BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16146542)

  • 1. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
    Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
    Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
    Bueno C; Almeida J; Lucio P; Marco J; Garcia R; de Pablos JM; Parreira A; Ramos F; Ruiz-Cabello F; Suarez-Vilela D; San Miguel JF; Orfao A
    Haematologica; 2004 Jan; 89(1):58-69. PubMed ID: 14754607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
    Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
    Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
    Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
    Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.
    Narita M; Kuroha T; Watanabe N; Hashimoto S; Tsuchiyama J; Tochiki N; Saitoh A; Satoh N; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
    Acta Haematol; 2008; 120(2):91-9. PubMed ID: 18948686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
    Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
    Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
    Jacob MC; Chaperot L; Mossuz P; Feuillard J; Valensi F; Leroux D; Béné MC; Bensa JC; Brière F; Plumas J
    Haematologica; 2003 Aug; 88(8):941-55. PubMed ID: 12935983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes.
    Giagounidis AA; Heinsch M; Haase S; Aul C
    Ann Hematol; 2004 Nov; 83(11):716-21. PubMed ID: 15316755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies.
    Trimoreau F; Donnard M; Turlure P; Gachard N; Bordessoule D; Feuillard J
    Haematologica; 2003 Mar; 88(3):ELT10. PubMed ID: 12651292
    [No Abstract]   [Full Text] [Related]  

  • 14. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples.
    Xu Y; McKenna RW; Asplund SL; Kroft SH
    Am J Clin Pathol; 2002 Nov; 118(5):758-64. PubMed ID: 12428797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry.
    Lukić A; Vasilijić S; Majstorović I; Vucević D; Mojsilović S; Gazivoda D; Danilović V; Petrović R; Colić M
    Int Endod J; 2006 Aug; 39(8):626-36. PubMed ID: 16872457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
    Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
    Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
    Ferran M; Gallardo F; Ferrer AM; Salar A; Pérez-Vila E; Juanpere N; Salgado R; Espinet B; Orfao A; Florensa L; Pujol RM
    Br J Dermatol; 2008 May; 158(5):1129-33. PubMed ID: 18294313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
    Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
    Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.